"Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis." (vol 17, pg 755, 2021)

被引：0
|
作者：
Emersic, Andreja [1 ,2 ]
机构：
[1] Univ Med Ctr Ljubljana, Dept Neurol, Ljubljana, Slovenia
[2] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia
来源：
ALZHEIMERS & DEMENTIA | 2023年 / 19卷 / 08期
关键词：
D O I：
10.1002/alz.13121
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：3760 / 3760
页数：1
相关论文
共 12 条
  • [1] Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis
    Karikari, Thomas K.
    Emersic, Andreja
    Vrillon, Agathe
    Lantero-Rodriguez, Juan
    Ashton, Nicholas J.
    Kramberger, Milica Gregoric
    Dumurgier, Julien
    Hourregue, Claire
    Cucnik, Sasa
    Brinkmalm, Gunnar
    Rot, Uros
    Zetterberg, Henrik
    Paquet, Claire
    Blennow, Kaj
    ALZHEIMERS & DEMENTIA, 2021, 17 (05) : 755 - 767
  • [2] Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification
    Barthelemy, Nicolas R.
    Bateman, Randall J.
    Hirtz, Christophe
    Marin, Philippe
    Becher, Francois
    Sato, Chihiro
    Gabelle, Audrey
    Lehmann, Sylvain
    ALZHEIMERS RESEARCH & THERAPY, 2020, 12 (01)
  • [3] Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer’s disease and PET amyloid-positive patient identification
    Nicolas R. Barthélemy
    Randall J. Bateman
    Christophe Hirtz
    Philippe Marin
    François Becher
    Chihiro Sato
    Audrey Gabelle
    Sylvain Lehmann
    Alzheimer's Research & Therapy, 12
  • [4] Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease
    Janelidze, Shorena
    Bali, Divya
    Ashton, Nicholas J.
    Barthelemy, Nicolas R.
    Vanbrabant, Jeroen
    Stoops, Erik
    Vanmechelen, Eugeen
    He, Yingxin
    Dolado, Anna Orduna
    Triana-Baltzer, Gallen
    Pontecorvo, Michael J.
    Zetterberg, Henrik
    Kolb, Hartmuth
    Vandijck, Manu
    Blennow, Kaj
    Bateman, Randall J.
    Hansson, Oskar
    BRAIN, 2023, 146 (04) : 1592 - 1601
  • [5] CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
    Nicolas R. Barthélemy
    Benjamin Saef
    Yan Li
    Brian A. Gordon
    Yingxin He
    Kanta Horie
    Erik Stomrud
    Gemma Salvadó
    Shorena Janelidze
    Chihiro Sato
    Vitaliy Ovod
    Rachel L. Henson
    Anne M. Fagan
    Tammie L. S. Benzinger
    Chengjie Xiong
    John C. Morris
    Oskar Hansson
    Randall J. Bateman
    Suzanne E. Schindler
    Nature Aging, 2023, 3 : 391 - 401
  • [6] CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease
    Barthelemy, Nicolas R.
    Saef, Benjamin
    Li, Yan
    Gordon, Brian A.
    He, Yingxin
    Horie, Kanta
    Stomrud, Erik
    Salvado, Gemma
    Janelidze, Shorena
    Sato, Chihiro
    Ovod, Vitaliy
    Henson, Rachel L.
    Fagan, Anne M.
    Benzinger, Tammie L. S.
    Xiong, Chengjie
    Morris, John C.
    Hansson, Oskar
    Bateman, Randall J.
    Schindler, Suzanne E.
    NATURE AGING, 2023, 3 (04): : 391 - +
  • [7] Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ pathology are detected
    Suarez-Calvet, Marc
    Karikari, Thomas K.
    Ashton, Nicholas J.
    Lantero Rodriguez, Juan
    Mila-Aloma, Marta
    Gispert, Juan Domingo
    Salvado, Gemma
    Minguillon, Carolina
    Fauria, Karine
    Shekari, Mahnaz
    Grau-Rivera, Oriol
    Arenaza-Urquijo, Eider M.
    Sala-Vila, Aleix
    Sanchez-Benavides, Gonzalo
    Gonzalez-de-Echavarri, Jose Maria
    Kollmorgen, Gwendlyn
    Stoops, Erik
    Vanmechelen, Eugeen
    Zetterberg, Henrik
    Blennow, Kaj
    Molinuevo, Jose Luis
    EMBO MOLECULAR MEDICINE, 2020, 12 (12)
  • [8] Plasma p-tau217 in Alzheimer's disease: Lumipulse and ALZpath SIMOA head-to-head comparison (vol 148, pg 408, 2025)
    Pilotto, Andrea
    Quaresima, Virginia
    Trasciatti, Chiara
    Tolassi, Chiara
    Bertoli, Diego
    Mordenti, Cristina
    Galli, Alice
    Rizzardi, Andrea
    Caratozzolo, Salvatore
    Zancanaro, Andrea
    Contador, Jose
    Hansson, Oskar
    Palmqvist, Sebastian
    De Santis, Giovanni
    Zetterberg, Henrik
    Blennow, Kaj
    Brugnoni, Duilio
    Suarez-Calvet, Marc
    Ashton, Nicholas J.
    Padovani, Alessandro
    BRAIN, 2025,
  • [9] Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts
    Juan Lantero-Rodriguez
    Agathe Vrillon
    Aida Fernández-Lebrero
    Paula Ortiz-Romero
    Anniina Snellman
    Laia Montoliu-Gaya
    Wagner S. Brum
    Emmanuel Cognat
    Julien Dumurgier
    Albert Puig-Pijoan
    Irene Navalpotro-Gómez
    Greta García-Escobar
    Thomas K. Karikari
    Eugeen Vanmechelen
    Nicholas J. Ashton
    Henrik Zetterberg
    Marc Suárez-Calvet
    Claire Paquet
    Kaj Blennow
    Alzheimer's Research & Therapy, 15
  • [10] Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts
    Lantero-Rodriguez, Juan
    Vrillon, Agathe
    Fernandez-Lebrero, Aida
    Ortiz-Romero, Paula
    Snellman, Anniina
    Montoliu-Gaya, Laia
    Brum, Wagner. S. S.
    Cognat, Emmanuel
    Dumurgier, Julien
    Puig-Pijoan, Albert
    Navalpotro-Gomez, Irene
    Garcia-Escobar, Greta
    Karikari, Thomas K.
    Vanmechelen, Eugeen
    Ashton, Nicholas. J. J.
    Zetterberg, Henrik
    Suarez-Calvet, Marc
    Paquet, Claire
    Blennow, Kaj
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
12